References
- Aalen, O.O. (1978). Nonparametric inference for a family of counting processes. Annals of Statistics 6:701–726.
- Andersen, P. K., Borgan, O., Gill, R. D., and Kidding, N. (1982). Linear nonparametric tests for comparison of counting processes with application to censored survival data (with discussion). International Statistical Review 50:219–258.
- Chang, M. N., Therneau, T. M., Wieand H. S., Cha, S. S. (1987). Designs for group sequential phase II clinical trials. Biometrics 43:865–874.
- Fleming, T. R., and Harrington, D. P. (1991). Counting Processes and Survival Analysis. New York: Wiley.
- George, S. L., and Desu, M. M. (1973). Planning the size and duration of a trial studying the time to some critical event. Journal of Chronic Disease 27:15–24.
- Lachin, J. M. (1981). Introduction to sample size determination and power analysis for clinical trials. Controlled Clinical Trials 2:93–113.
- Lachin, J. M. (2005). A review of methods for futility stopping based on conditional power. Statistics in Medicine 24:2747–2764.
- Lakatos, E. (1988). Sample sizes based on the log-rank statistic in complex clinical trials. Biometrics 44:229–241.
- Nelson, W. (1969). Hazard Plotting for Incomplete Failure Data. Journal of Quality Technology 1:27–52.
- Pampallona, S., and Tsiatis, A. A. (1994). Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis. Journal of Statistical Planning and Inference 42:19–35.
- Pasternack, B. S., and Gilbert, H. S. (1971). Planning the duration of long-term survival time studies designed for accrual by cohorts. Journal of Chronic Disease 24:13–24
- Peto, R. and Peto, J. (1972). Asymptotically efficient rank invariant test procedures (with discussion). Journal of the Royal Statistical Society, Series A 135:185–206.
- Rubinstein, L., Gail, M., and Santner, T. (1981). Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. Journal of Chronic Disease 27:15–24.
- Schoenfeld, D. A. (1983). Sample size formula for the proportional hazards regression model. Biometrics 39:499–503.
- Simon, R. (1989). Optimal two-stage designs for phase II clinical trials. Controlled Clinical Trials 10:1–10.
- Slud, E.V., and Wei, L. J. (1982). Two-Sample repeated significance tests based on the modified Wilcoxon statistic. Journal of American Statistical Society 77:862–868.
- Tsiatis, A. A. (1982). Repeated significance testing for a general class of statistics used in censored survival analysis. Journal of American Statistical Society 77:855–861.
- Wieand, S., Schroeder, G., and O’Fallon, J. R. (1994). Stopping when the experimental regimen does not appear to help. Statistics in Medicine 13:1453–1458.
- Yateman, N. A., and Skene, A. M. (1992). Sample size for proportional hazards survival studies with arbitrary patient entry and loss to follow-up distributions. Statistics in Medicine 11:1103–1113.